POLYMERIC NANOVACCINES AND USES THEREOF

MALARIA IMMUNOGEN AND METHODS OF USING SAME

IMMUNOGENIC COMPOSITIONS AGAINST THE OMICRON VARIANT OF SEVERE ACUTE RESPITORY SYNDROME CORONAVIRUS 2 (SARS-COV-2)

NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS INCLUDING NEURONAL AND BRAIN TUMORS

TRITERPENE SAPONIN ANALOGUES

METHODS AND COMPOSITIONS FOR STIMULATING IMMUNE RESPONSE

IMMUNOMODULATING POLYNUCLEOTIDES, ANTIBODY CONJUGATES THEREOF, AND METHODS OF THEIR USE

THERAPEUTIC COMPOUND AND METHOD OF PREPARING A THERAPEUTIC VACCINE FOR THE TREATMENT OF ALLERGIC AND AUTOIMMUNE DISEAES USING IMMUNIZATION WITH ENGINEERED BACTERIAL DNA OR CpG MOTIFS DERIVIDE FROM COMMENSAL BACTERIA SUCH AS Bifidobacterium longun subsp. infantis.

DIPHTHERIA-TETANUS-PERTUSSIS COMPOUND ADJUVANT COMBINED VACCINE

RESPIRATORY SYNCYTIAL VIRUS (RSV) POLYANHYDRIDE NANOPARTICLE VACCINE

COMPOUNDS INCLUDING A MUTANT KRAS SEQUENCE AND A LIPID AND USES THEREOF

PEPTIDE AND NUCLEIC ACID METHODS TO MODULATE DELIVERY OF NUCLEIC ACID STRUCTURES, POLYPEPTIDES, AND THEIR CARGOES

TARGETING moDC TO ENHANCE VACCINE EFFICACY ON MUCOSAL SURFACE

PHARMACEUTICAL COMPOSITION FOR PREVENTING HEPATITIS B VIRUS INFECTION AND USE THEREOF

PEPTIDE-LOADED ANTIGEN PRESENTING CELL-DERIVED EXTRACELLULAR BLEBS AS A MOLECULARLY TARGETED VACCINE

ALPHA-HEMOLYSIN COMPOSITIONS AND METHODS FOR IMMUNIZATION AGAINST STAPHYLOCOCCUS AUREUS

IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATED CAPSULAR SACCHARIDE ANTIGENS, KITS COMPRISING THE SAME AND USES THEREOF

DNA ORIGAMI VACCINES

Pharmaceutical Composition, Preparation Method and Use Thereof

VACCINE AGAINST PANCREATIC CANCER, AND MEDICAL USE THEREOF

COMBINATION THERAPY WITH NEOANTIGEN VACCINE

VACCINES TARGETING C. ACNES HYALURONIDASE FOR PROPHYLAXIS AND TREATMENT OF ACNE VULGARIS

LIPID NANOPARTICLES FOR DELIVERY OF NUCLEIC ACIDS AND VACCINES

NANOPARTICLES AS CARRIER-SYSTEM FOR ADJUVANTS/ANTIGENS

PREFUSION RSV F PROTEINS AND THEIR USE

RSV VACCINE AS WELL AS PREPARATION METHOD THEREOF AND USE THEREOF

SUBLINGUAL NANOFIBER VACCINES AND METHODS OF MAKING AND USING SAME

COMPOSITIONS AND METHODS FOR DELIVERY OF BIOMACROMOLECULE AGENTS

PREFUSION RSV F PROTEINS AND THEIR USE

CANCER ANTIGENS AND METHODS

VACCINE COMPOSITIONS AND USES THEREOF

IMMUNOGENICITY OF A CPG-ADJUVANTED RECOMBINANT PLAGUE VACCINE

MUTANT CALR-PEPTIDE BASED VACCINE

SARS-CoV-2 Vaccine Constructs

USES OF MODIFIED RNA ENCODING RETINALDEHYDE DEHYDROGENASE

NEOANTIGEN VACCINES FOR CANCER PREVENTION

Compositions of Phosphorylated Tau Peptides and Uses Thereof

VACCINE ADJUVANT, AND PREPARATION METHOD THEREFOR AND USE THEREOF

VACCINE COMPOSITION FOR BREAKING SELF-TOLERANCE

METHODS FOR TREATING CANCERS WITH MODIFIED PBMCS

LENTIVIRAL VECTORS TARGETING ANTIGENS TO MHC-II PATHWAY AND INDUCING PROTECTIVE CD8+ AND CD4+ T-CELL IMMUNITY IN A HOST

CHEMICAL SCREEN OF MODULATORS FOR VACCINE ADJUVANTS

IMMUNOGENIC COMPOSITIONS COMPRISING MYCOBACTERIUM TUBERCULOSIS POLYPEPTIDES AND FUSIONS THEREOF

VACCINE AGAINST INFECTIOUS BRONCHITIS

SPHERICAL NUCLEIC ACID-BASED CONSTRUCTS AS IMMUNOSTIMULATORY AGENTS FOR PROPHYLACTIC AND THERAPEUTIC USE

IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATED ESCHERICHIA COLI SACCHARIDES AND USES THEREOF

THERMOSTABLE PARTICLE-BASED COMPOSITIONS AND MANUFACTURING PROCESS

Method of Safe Administration of Phosphorylated TAU Peptide Vaccine

TREATMENT OF CANCER USING MRNA-MEDIATED VIRUS VACCINATION ANTIGENS DELIVERED BY ATTENUATED BACTERIA

METHODS TO STIMULATE IMMUNE RESPONSES TO MUTANT RAS USING ANUCLEATE CELLS

MICROSPHERE FORMULATIONS COMPRISING MULTIPLE NON-IDENTICAL PEPTIDES AND METHODS FOR MAKING THE SAME

VETERINARY VACCINES AND METHODS FOR THE TREATMENT OF PASTEURELLA MULTOCIDA INFECTIONS IN FOOD PRODUCTION ANIMALS

ARTIFICIAL PROMISCUOUS T HELPER CELL EPITOPES THAT FACILITATE TARGETED ANTIBODY PRODUCTION WITH LIMITED T CELL INFLAMMATORY RESPONSE

COMPOSITIONS AND METHODS FOR MUCOSAL VACCINATION AGAINST SARS-COV-2

MODIFIED EXOSOMES AND METHODS OF USE

ANTIMICROBIAL PEPTIDE DERIVATIVE AND USE THEREOF

COMPOUNDS INCLUDING A MUTANT KRAS SEQUENCE AND A LIPID AND USES THEREOF

TARGETING JUNCTIONAL EPITHELIUM IN THE GINGIVAL CREVICE FOR IMMUNE MODULATION

VACCINE COMPOSITION COMPRISING AN ANTIGEN AND A TLR3 AGONIST

MEDICAL AGENT INCLUDING ADJUVANT AND COMPOSITE OF PHOTOSENSITIVE MOLECULE AND MOLECULE BINDING TO CANCER-SPECIFIC CELL SURFACE MOLECULE

DENDRITIC CELL TARGETING FILAMENTOUS PHAGE-BASED CANCER TREATMENT VACCINE

IMMUNOSTIMULATORY COMPOSITIONS

RNA CONTAINING COMPOSITION FOR TREATMENT OF TUMOR DISEASES

CLOSTRIDIUM DIFFICILE VACCINE

IMMUNOTHERAPEUTIC CONSTRUCTS AND METHODS OF THEIR USE

VACCINE COMPOSITION COMPRISING AN ANTIGEN AND A TLR3 AGONIST

A NOVEL CATIONIC ADJUVANT COMPOSITION

MDR E. COLI IMMUNOGEN

IMMUNOGENICITY OF A CPG-ADJUVANTED HERPES ZOSTER VACCINE

IMMUNOGENIC COMPOSITIONS COMPRISING A RECOMBINANT NEURAMINIDASE AND CpG OLIGONUCLEOTIDE ADJUVANT, AND USES THEREOF

SELF-ASSEMBLING PROTEIN NANOPARTICLES ENCAPSULATING IMMUNOSTIMULATORY NUCLEID ACIDS

PEPTIDE CONJUGATE VACCINE COMPOSITIONS AND METHODS FOR THE TREATMENT OF ALZHEIMER'S DISEASE

COMPOSITIONS FOR STIMULATION OF MAMMALIAN INNATE IMMUNE RESISTANCE TO PATHOGENS

Anti-Alpha-Synuclein Therapeutic Vaccines

LIPOSOMES CONTAINING PHOSPHORYLATED TAU PEPTIDES FOR INDUCING SUSTAINED IMMUNE RESPONSES

COMPOSITIONS CONTAINING POLYNUCLEOTIDE AMPHIPHILES AND METHODS OF USE THEREOF

Liposomes Containing Phosphorylated Tau Peptides for Inducing Sustained Immune Responses

METHOD OF TREATING PRECLINICIAL ALZHEIMER'S DISEASE

HIV PRE-IMMUNIZATION AND IMMUNOTHERAPY

CHIMERIC PROTEIN PRODUCTION PROCESS, CHIMERIC PROTEIN, GENE, IMMUNOGENIC COMPOSITION AND USES

OIL-BASED ADJUVANTS

METHODS OF TREATING IMMUNE DYSFUNCTION IN LIVER CANCER WITH TOLL-LIKE RECEPTOR AGONISTS

POLYMER ADJUVANT

INJECTABLE HYDROGEL FOR SUSTAINED CO-DELIVERY OF AN ANTIGEN AND AN ADJUVANT, AND USES THEREOF

COMPOSITION FOR ENHANCING IMMUNOGENICITY

VACCINATION WITH MICA/B ALPHA 3 DOMAIN FOR THE TREATMENT OF CANCER

USE OF TRIMANGANESE TETRAOXIDE PARTICLES IN PREPARATION OF VACCINE ADJUVANT

FREEZE-DRIED VIRAL COMBINATION VACCINE COMPOSITIONS AND PROCESS FOR PREPARATION THEREOF

METHOD OF SAFE ADMINISTRATION OF TAU PHOSPHOPEPTIDE CONJUGATE

RECOMBINANT MULTIVALENT VACCINE

Pro-Inflammatory and Adjuvant Functions of Toll-Like Receptor 4 Antagonists

COMPOSITIONS AND METHODS FOR INDUCING AND ENHANCING AN IMMUNE RESPONSE

PEPTIDE VACCINES AND PEMBROLIZUMAB FOR TREATING BREAST CANCER

COMPOUNDS INCLUDING A MUTANT KRAS SEQUENCE AND A LIPID AND USES THEREOF

NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS

IDENTIFICATION OF IMMUNOGENIC MUTANT PEPTIDES USING GENOMIC, TRANSCRIPTOMIC AND PROTEOMIC INFORMATION

PRO-INFLAMMATORY AND ANTI-CANCER FUNCTIONS OF TOLL-LIKE RECEPTOR 4 ANTAGONISTS

MUCOSAL VACCINE, METHODS OF USE AND ADMINISTRATION THEREOF

DESIGN OF IMMUNOSTIMULATORY PROTEIN-CORE SPHERICAL NUCLEIC ACIDS

PHARMACEUTICAL COMPOSITION

SURVIVIN AND MAGE-A9 DUAL-TARGETED IMMUNOTHERAPY

HBV VACCINE INDUCING PRES-SPECIFIC NEUTRALIZING ANTIBODIES

POLYMERIC NANOPARTICLE GENETIC VACCINES

RECOMBINANT CHIMERIC PROTEIN, USE THEREOF, AND COMPOSITION

VACCINE COMPOSITIONS

UNIVERSAL VACCINE FOR INFLUENZA VIRUS BASED ON TETRAMERIC M2 PROTEIN INCORPORATED INTO NANODISCS

Novel Adjuvant Compositions

COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTIONS THROUGH STIMULATED INNATE IMMUNITY IN COMBINATION WITH ANTIVIRAL COMPOUNDS

METHODS FOR THE PREVENTION AND TREATMENT OF SYNUCLEINOPATHIES

METHODS FOR PREPARING COMPLEX FOR ENHANCING IMMUNE RESPONSE

Compositions and Methods for Antigen Targeting to CD180

ADJUVANTED VACCINES WITH NON-VIRION ANTIGENS PREPARED FROM INFLUENZA VIRUSES GROWN IN CELL CULTURE

SUBUNIT VACCINES WITH DINUCLEOTIDE-LOADED HYDROGEL ADJUVANT

PORCINE BIVALENT SUBUNIT VACCINE COMPOSITION IN A SINGLE DOSE

INACTIVATED SARS-COV-2 VIRUS VACCINE

Adjuvants

VACCINE COMPOSITION COMPRISING ENCODED ADJUVANT

COMPOSITIONS FOR INDUCING AN IMMUNE RESPONSE

COMPOSITIONS AND METHODS TO INCREASE CORONAVIRUS IMMUNE RESPONSE

VIRUS-LIKE PARTICLE VACCINE FOR CORONAVIRUS

COMBINED AGONIST ADJUVANT FOR CORONAVIRUS VACCINE

Phosphorylated Polypeptide Antigen Vaccine, Preparation Method Therefor and Application Thereof

APPLICATION OF ARTIFICIALLY SYNTHESIZED CPG SINGLE-STRANDED DEOXYOLIGONUCLEOTIDE IN VACCINES

HEPATITIS C VIRUS IMMUNOGENIC COMPOSITIONS AND METHODS OF USE THEREOF

HIV PRE-IMMUNIZATION AND IMMUNOTHERAPY

METHODS AND COMPOSITIONS FOR TARGETING OF ANTIGENS AND OTHER POLYPEPTIDES TO FIRST RESPONDER DENDRITIC CELLS

ANTI-TUMOR COMPOSITIONS AND USES THEREOF

VACCINE COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF URINARY TRACT INFECTIONS

Combination Therapy Tumour Cell Vaccine

LIPIDOID NANOPARTICLES FOR THE TREATMENT OF DISEASES AND DISORDERS

Prefusion RSV F proteins and their use

ADJUVANT ACTIVITY ENHANCER AND ADJUVANT COMPOSITION

NANOPARTICLES AS CARRIER-SYSTEM FOR ADJUVANTS/ANTIGENS

IMMUNOGENIC COMPOSITION CONTAINING AN ANTIGEN AND AN ADJUVANT COMPRISING AL-MOFS

COMPOSITIONS AND METHODS FOR PREVENTING RSV AND PIV3 INFECTIONS

IMMUNOGENIC COMPOSITIONS AND METHODS FOR IMMUNIZATION AGAINST VARIANTS OF SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2)

Foot-and-mouth disease vaccine

GRAPHENE OXIDE NANOPARTICLES AND METHODS OF USE FOR STIMULATING IMMUNE RESPONSES

Zika Virus Polypeptides

IMMUNOGENIC COMPOSITIONS AND METHODS FOR ELICITING AN IMMUNE RESPONSE AGAINST CLOSTRIDIOIDES (CLOSTRIDIUM) DIFFICILE

HUMAN METAPNEUMO VIRUS VACCINE

TARGETING JUNCTIONAL EPITHELIUM IN THE GINGIVAL CREVICE FOR IMMUNE MODULATION

ADJUVANTED MUCOSAL SUBUNIT VACCINES FOR PREVENTING SARS-COV-2 TRANSMISSION AND INFECTION

3'3' CYCLIC DINUCLEOTIDES CONTAINING ISONUCLEOTIDIC UNITS

TARGETING MULTIPLE T CELL TYPES USING SPHERICAL NUCLEIC ACID VACCINE ARCHITECTURE

IMMUNOGENICITY OF A CPG-ADJUVANTED RECOMBINANT PLAGUE VACCINE

CATH2 AND DERIVATIVES FOR INHIBITING STREPTOCOCCUS SUIS

STING DEPENDENT ADJUVANTS

TAU PEPTIDE IMMUNOGEN CONSTRUCTS

IMMUNOGENIC COMPOSITIONS COMPRISING MYCOBACTERIUM TUBERCULOSIS POLYPEPTIDES AND FUSIONS THEREOF

COMPLEXES FOR DELIVERY OF ANTIGENIC PEPTIDES

VACCINE COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF URINARY TRACT INFECTIONS

PHARMACEUTICAL COMPOSITION COMPRISING TOLL-LIKE RECEPTOR AGONIST AND STIMULATOR OF INTERFERON GENES AGONIST AND USE THEREOF

SILICIFIED TUMOR CELL COMPOSITIONS AND METHODS

SOLE USE OF POLYMERSOME ASSOCIATED ADJUVANT FOR STIMULATING AN IMMUNE RESPONSE

PRE-IMMUNIZATION AND IMMUNOTHERAPY

Tuberculosis Compositions And Methods Of Using The Same

METHODS AND COMPOSITIONS FOR TREATING CANCERS USING ANTISENSE

NOVEL COMPOSITIONS BASED ON POLYINOSINIC-POLYCYTIDYLIC ACID

NOVEL COMPOSITIONS BASED ON POLYINOSINIC-POLYCYTIDYLIC ACID

NOVEL THI-INDUCING ADJUVANT COMPRISING COMBINATION OF DIFFERENT NUCLEIC ACID ADJUVANTS AND USE OF SAME

ADJUVANT COMPRISING A GLYCOARCHAEOL AND AN IMMUNOSTIMULANT

IMMUNOSTIMULATORY OLIGONUCLEOTIDES

IMMUNOGENIC CONSTRUCTS, COMPOSITIONS, AND METHODS FOR INDUCING IMMUNE RESPONSE

SELF-ASSEMBLING PROTEIN NANOPARTICLES ENCAPSULATING IMMUNOSTIMULATORY NUCLEID ACIDS

IL-12 POLYPEPTIDES, IL-15 POLYPEPTIDES, IL-18 POLYPEPTIDES, CD8 POLYPEPTIDES, COMPOSITIONS, AND METHODS OF USING THEREOF

CD200 INHIBITORS AND METHODS OF USE THEREOF

Lipids and compositions for the delivery of therapeutics

SYSTEMS AND METHODS FOR NUCLEIC ACID EXPRESSION IN VIVO

METHODS AND COMPOSITIONS FOR ADAPTIVE IMMUNE MODULATION

Vaccine Composition for Preventing Tuberculosis Comprising Chorismate Mutase

Combined Preparation

Prefusion RSV F proteins and their use

METHODS OF TREATING HYPERGLYCEMIA AND SUPPRESSING ONSET OF TYPE 1 DIABETES

COMPLEX OF BETA-GLUCAN AND NUCLEIC ACID HAVING CONTROLLED PARTICLE SIZE

Oil-based adjuvants

PHARMACEUTICAL COMPOSITION, PHARMACEUTICAL COMBINED FORMULATION, AND COMBINED FORMULATION KIT FOR PREVENTION OR TREATMENT OF CHRONIC HEPATITIS B, EACH COMPRISING, AS ACTIVE INGREDIENT, ORAL ANTIVIRAL AGENT AND THERAPEUTIC VACCINE INCLUDING LIPOPEPTIDE AND POLY(I:C) ADJUVANT

INJECTABLE PREFORMED MACROSCOPIC 3-DIMENSIONAL SCAFFOLDS FOR MINIMALLY INVASIVE ADMINISTRATION

MODULATING TH1/TH2 IMMUNE RESPONSE BY ADMINISTERING TWO POPULATIONS OF POLYMERSOMES HAVING AN ASSOCIATED ANTIGEN AND AN ASSOCIATED ADJUVANT

NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS

METHODS OF TREATING DIFFUSE LARGE B-CELL LYMPHOMA

Structure-Function Relationships in the Development of Immunotherapeutic Agents

HERPESVIRUS POLYEPITOPE VACCINES

Vaccines Comprising Mycobacterium Leprae Polypeptides for the Prevention, Treatment, and Diagnosis of Leprosy

Method of Safe Administration of Phosphorylated TAU Peptide Vaccine

DNA NANOVACCINE, PREPARATION METHOD THEREFOR AND USE THEREOF

RSV F protein compositions and methods for making same

MEMBRANE-BOUND IL-15, CD8 POLYPEPTIDES, CELLS, COMPOSITIONS, AND METHODS OF USING THEREOF

Production Of Vaccines Comprising Inactivated SARS-COV-2 Viral Particles

Liposomes Containing Phosphorylated Tau Peptides for Inducing Sustained Immune Responses

IMMUNOSTIMULATORY OLIGONUCLEOTIDES

Adjuvant based on peptide nucleic acid

TARGETING DELIVERY SYSTEM LOADED WITH WHOLE-CELL COMPONENTS AND USE THEREOF

COMPLEXES FOR THE DELIVERY OF PROTEINACEOUS AGENTS

METHODS OF TREATING A LATENT HIV-1 INFECTION USING NON-CODING DEOXYRIBONUCLEIC ACIDS

FcRn-targeted mucosal vaccination against influenza infections

PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS

MDR immunogen

PEPTIDE IMMUNOGENS AND FORMULATIONS THEREOF TARGETING MEMBRANE-BOUND IgE FOR TREATMENT OF IgE MEDIATED ALLERGIC DISEASES

STABILIZED SOLUBLE PRE-FUSION RSV F POLYPEPTIDES

COMPOSITIONS AND METHODS FOR INDUCING AN IMMUNE RESPONSE AGAINST CORONAVIRUS

Heterologous Administration of Tau Vaccines

ANTI-TUMOR NANO ADJUVANT BASED ON VESICLE FORMED BY CROSS-LINKED BIODEGRADABLE POLYMER, PREPARATION METHOD THEREFOR AND USE THEREOF

VACCINE AGAINST HUMAN-PATHOGENIC CORONAVIRUSES

TUMOR VACCINATION IN COMBINATION WITH HEMATOPOIETIC CELL TRANSPLANTATION FOR CANCER THERAPY

INTERFERON- INDUCING OLIGONUCLEOTIDE DUPLEXES AND METHODS OF USE

GONORRHEA SUBUNIT VACCINE

Recombinant HIV-1 envelope proteins and their use

CORONAVIRUS VACCINES COMPRISING A TLR9 AGONIST

VACCINE THERAPY FOR RAN PROTEIN DISEASES

PRIME-BOOST REGIMENS INVOLVING ADMINISTRATION OF AT LEAST ONE mRNA CONSTRUCT

Methods for preparing complex for enhancing immune response

TLR3 AND TLR9 AGONISTS AS VACCINE ADJUVANTS FOR ANTI-CANCER DNA VACCINES

ADJUVANTS FOR SEVERE ACUTE RESPIRATORY SYNDROME-RELATED CORONAVIRUS (SARS-COV) VACCINES

ENPP1 INHIBITORS AND METHODS OF MODULATING IMMUNE RESPONSE

IDENTIFICATION OF HLA-RESTRICTED PRAME PEPTIDE EPITOPES, PRAME-SPECIFIC T CELLS SUITABLE FOR "OFF-THE-SHELF" TREATMENT OF CANCER EXPRESSING PRAME

INDIVIDUALIZED VACCINES FOR CANCER

COMBINATION THERAPY WITH NEOANTIGEN VACCINE

IPSC-BASED VACCINE AS A PROPHYLACTIC AND THERAPEUTIC TREATMENT FOR CANCER

Immunostimulatory compositions

HUMAN CYTOMEGALOVIRUS POLYEPITOPE VACCINE COMPOSITION

CITRULLINATED NUCLEOPHOSMIN PEPTIDES AS CANCER VACCINES

RNA-BASED ADJUVANT TO ENHANCE THE IMMUNE RESPONSE TO VACCINES AND THERAPEUTICS

IMMUNOGENIC COMPOSITION COMPRISING CYAA-DERIVED POLYPEPTIDE PROMOTING A TH1/TH17-ORIENTED IMMUNE RESPONSE

CPG ODN HAVING IMMUNOREGULARTORY FUNCTION AND USE THEREOF

APPLICATION OF HETEROCYCLIC COMPOUND CONTAINING AT LEAST TWO SULFUR ATOMS IN PREPARING NANO-VACCINE AND PREPARED NANO-VACCINE

TREATMENT INVOLVING NON-IMMUNOGENIC RNA FOR ANTIGEN VACCINATION

IMMUNE INDUCER CONTAINING POLYNUCLEOTIDE-PEPTIDE CONJUGATE AND PHARMACEUTICAL COMPOSITION CONTAINING SAME

Compositions and methods for antigen targeting to CD180

CORONAVIRUS VACCINES COMPRISING A TLR9 AGONIST

Malaria immunogen and methods for using same

Methods and composition for induction of immune response

METHODS AND VACCINES FOR INDUCING IMMUNE RESPONSES TO MULTIPLE DIFFERENT MHC MOLECULES

PEPTIDE IMMUNOGENS TARGETING PCSK9 AND FORMULATIONS THEREOF FOR PREVENTION AND TREATMENT OF PCSK9-MEDIATED DISORDERS

MICROEMULSION-BASED VACCINE DELIVERY SYSTEM, PREPARATION METHOD THEREFOR AND USE THEREOF

OPTIMIZATION OF PEPTIDE-MELANIN BINDING

COMPOSITIONS OF ALUM NANOPARTICLES FOR IMMUNOMODULATION AND METHODS FOR PRODUCING THE SAME

PHARMACEUTICAL COMPOSITION AND USE THEREOF

Methods and compositions for stimulating immune response

PHARMACEUTICAL COMPOSITION AND USE THEREOF

Nucleic acid vaccination using neo-epitope encoding constructs

SHINGLES VACCINES COMPRISING A TLR9 AGONIST

METABOLITE-BASED POLYMERS, MICROPARTICLES, AND NANOPARTICLES FOR IMMUNOTHERAPY AND METHODS OF TREATING A DISEASE OR DISORDER

TREATMENT METHODS

PERSONALIZED TUMOR VACCINE AND USE THEREOF FOR CANCER IMMUNOTHERAPY

Pro-inflammatory and anti-cancer functions of toll-like receptor 4 antagonists

Composition comprising PIC for treatment of cancer

VACCINATION AGAINST ANTIGENS INDUCED IN PATHOGEN-INFECTED CELLS

Pro-inflammatory and adjuvant functions of toll-like receptor 4 antagonists

IMMUNOSTIMULATORY COMPOSITION AND USE THEREOF

CpG-adjuvanted SARS-CoV-2 virus vaccine

CELL SURFACE ANCHORING ANTIGEN CONJUGATES TO TREAT CANCER

Recombinant Human Papillomavirus Vaccine Composition and Use thereof

MESOPOROUS SILICA COMPOSITIONS COMPRISING INFLAMMATORY CYTOKINES FOR MODULATING IMMUNE RESPONSES

SMALL LIPID NANOPARTICLES, AND CANCER VACCINE INCLUDING SAME

GOLD NANOPARTICLES/NANOSHELLS IMMUNE CONJUGATES FOR ENHANCED IMMUNOTHERAPY AND PHOTOTHERMAL THERAPY FOR HEMATOLOGIC MALIGNANCIES

NUCLEIC ACIDS COMPRISING FORMULA (NuGlXmGnNv)a AND DERIVATIVES THEREOF AS IMMUNOSTIMULATING AGENT/ADJUVANT

FcRn-targeted mucosal vaccination against RSV

INTRATUMORAL ADMINISTRATION OF IMMUNE CELLULAR THERAPEUTICS

PHARMACEUTICAL COMPOSITION

ADOPTIVE CELL THERAPY USING SPHERICAL NUCLEIC ACIDS (SNAS)

INDUCED PLURIPOTENT STEM CELL-BASED CANCER VACCINES

Composite-type nano-vaccine particle

RSV F protein compositions and methods for making same

SARS-CoV-2 POLYPEPTIDES

MULTIGENIC MVA-SARS-COV-2 VACCINE

VACCINE AND METHOD FOR TREATING CANCER

Vaccine delivery method

Recombinant Herpes Zoster Vaccine Composition and Application Thereof

CD200 inhibitors and methods of use thereof

RSV F protein compositions and methods for making same

BIOMATERIAL-BASED ANTIGEN FREE VACCINE AND THE USE THEREOF

COMPOSITE ADJUVANT SYSTEM AND METHOD FOR PREPARING ADJUVANT

Methods and compositions for activation of innate immune responses through RIG-I like receptor signaling

IMMUNOACTIVE MICROPARTICLES AND USES THEREOF

MODIFIED VIRUS-LIKE PARTICLES OF CMV

ANTIVIRAL VACCINES USING SPHERICAL NUCLEIC ACIDS

CIRCULAR RNA MODIFICATION AND METHODS OF USE

A METHOD OF ELICITING AN IMMUNE RESPONSE BY ADMINISTERING A POPULATION OF POLYMERSOMES HAVING AN ASSOCIATED ANTIGEN TOGETHER WITH A POPULATION OF POLYMERSOMES HAVING AN ASSOCIATED ADJUVANT AS WELL AS COMPOSITIONS COMPRISING THE TWO POPULATIONS OF POLYMERSOMES

SELECTIVE LOCAL INHIBITION OF TNFR1-MEDIATED FUNCTIONS AT THE SITE OF ANTIGEN/ALLERGEN PRESENTATION

COMPOSITIONS AND METHODS FOR ENHANCING INNATE IMMUNITY IN A SUBJECT FOR TREATMENT OF INFECTIONS AND CANCER AND OTHER ACUTE AND CHRONIC CONDITIONS OF THE EYE

Multivalent delivery of immune modulators by liposomal spherical nucleic acids for prophylactic or therapeutic applications

NANOPARTICLES FOR USE IN REDIRECTION AGAINST THE TUMOUR OF A NON-TUMOUR SPECIFIC IMMUNE RESPONSE, BASED ON A PRE-EXISTING IMMUNITY

SENECAVIRUS A VIRUS STRAINS AND IMMUNOGENIC COMPOSITIONS THEREFROM

IMMUNOTHERAPEUTIC CONSTRUCTS AND METHODS OF THEIR USE

Formulations of PBMCs

PHARMACEUTICAL COMPOSITION CONTAINING STABILIZED NUCLEIC ACID ADJUVANT

FORMULATIONS OF ACTIVATING ANTIGEN CARRIERS

RSV F protein compositions and methods for making same

Methods and Devices for the Treatment of Food Allergies

TREATMENT METHODS

CD40 Specific DNA Aptamers as Vaccine Adjuvants

A Composition for the Delivery of Biologically Active Agents and Uses Thereof

DERIVATIVES OF GYLCERO-MANNO-HEPTOSE ADP FOR USE IN MODULATING IMMUNE RESPONSE

Medicine for treating cancer by administering a toll-like receptor agonist and LAG-3 IgG fusion protein

Vaccine against infectious bronchitis

3′3′-cyclic dinucleotide analogue comprising a cyclopentanyl modified nucleotide as sting modulator

Vaccine delivery systems using yeast cell wall particles

VACCINE COMPOSITIONS COMPRISING AN AMPHIPATHIC COMPOUND, A NEOANTIGEN AND A HYDROPHOBIC CARRIER, AND METHODS OF USE THEREOF

MRNA VACCINE